Article Versions Notes

Blumenthal JA, Smith PJ, Jiang W, Hinderliter A, Watkins LL, Hoffman BM, Kraus WE, Mabe S, Liao L, Davidson J, et al. Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial. Journal of Cardiovascular Development and Disease. 2022; 9(10):320. https://doi.org/10.3390/jcdd9100320

Blumenthal, James A., Patrick J. Smith, Wei Jiang, Alan Hinderliter, Lana L. Watkins, Benson M. Hoffman, William E. Kraus, Stephanie Mabe, Lawrence Liao, Jonathan Davidson, and et al. 2022. "Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial" Journal of Cardiovascular Development and Disease 9, no. 10: 320. https://doi.org/10.3390/jcdd9100320

Blumenthal, J. A., Smith, P. J., Jiang, W., Hinderliter, A., Watkins, L. L., Hoffman, B. M., Kraus, W. E., Mabe, S., Liao, L., Davidson, J., & Sherwood, A. (2022). Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial. Journal of Cardiovascular Development and Disease, 9(10), 320. https://doi.org/10.3390/jcdd9100320